Epidemiology of ciprofloxacin resistance among patients with methicillin-resistant Staphylococcus aureus.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  1990-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/JAC/26.4.567PMID 2254224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections

  1989cited by this paper
• Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones

  1989cited by this paper
• Ciprofloxacin resistance in methicillin-and gentamicin-resistantStaphylococcus aureus

  1989cited by this paper
• Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations

  1989cited by this paper
• Clindamycin for colonization and infection by methicillin-resistant Staphylococcus aureus

  1988cited by this paper
• The effect of ciprofloxacin on methicillin-resistant Staphylococcus aureus.

  1986cited by this paper
• Penetration of ciprofloxacin into kidney, fat, muscle and skin tissue

  1986cited by this paper
• Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus

  1986cited by this paper
• Ciprofloxacin-resistant staphylococci.

  1985cited by this paper
• Clinical resistance to long-term oral ciprofloxacin.

  1985cited by this paper
• Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus

  1985cited by this paper
• The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

  1985cited by this paper
• Analysis of plasmids in nosocomial strains of multiple-antibiotic-resistant Staphylococcus aureus

  1983cited by this paper
• Apparent absence of transferable resistance to nalidixic acid in pathogenic Gram-negative bacteria.

  1977cited by this paper

• Synergistic Antibacterial Performance of a Cu/WO 3 -Added PTFE Particulate Superhydrophobic Composite under Visible-Light Exposure

  2012cites this paper
• Corneal Collagen Cross-Linking Using Riboflavin and Ultraviolet-A Irradiation in Keratitis Treatment

  2012cites this paper
• Activity of Quinolones against Gram-Positive Cocci: Clinical Features

  2012cites this paper
• Antibacterial Activity of Hydrophobic Composite Materials Containing a Visible-Light-Sensitive Photocatalyst

  2011cites this paper
• Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis.

  2008cites this paper
• Methicillin-ResistantStaphylococcus aureus in Europe

  2005cites this paper
• Bacterial resistance to fluoroquinolones: Lessons to be learned

  2005cites this paper
• Quinolone resistance inPseudomonas aeruginosa andStaphylococcus aureus. Development during therapy and clinical significance

  2005cites this paper
• Antibiotic prescribing as a risk factor for MRSA.

  2005cites this paper
• Treatment of Infections of the Ears, Nose, and Throat and Nasal Carriage

  2003cites this paper
• The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.

  2002cites this paper
• Fluoroquinolone resistance among Gram-positive cocci.

  2002cites this paper
• Integrating Fluoroquinolones into the Hospital Formulary

  2001cites this paper
• Evolución de un brote epidémico por Staphylococcus Aureus resistente a la meticilina (SARM)

  2001cites this paper
• Emerging fluoroquinolone resistance in bacterial keratitis: A 5-year review

  1999cites this paper
• Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.

  1999cites this paper
• Clinical applications of quinolones.

  1998cites this paper
• The independent evolution of resistance to ciprofloxacin, rifampicin, and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995). Australian Group for Antimicrobial Resistance (AGAR).

  1998cites this paper
• Sensitivity to sparfloxacin and other antibiotics, of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory tract infections: a European multicentre study. SPAR Study Group. Surveillance Programme of

  1998cites this paper
• Antibiotics for treatment of infections caused by MRSA and elimination of MRSA carriage. What are the choices?

  1997cites this paper
• Frequency, clonal heterogeneity and antibiotic resistance of methicillin-resistant Staphylococcus aureus (MRSA) isolated in 1992-1994.

  1996cites this paper
• Infection surveillance and antibiotic utilization in a community-based skilled nursing facility

  1996cites this paper
• Different susceptibility of coagulase-positive and coagulase-negative staphylococci to ciprofloxacin.

  1996cites this paper
• Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

  1996cites this paper
• Staphylococcus aureus sensitivity to various antibiotics — A national survey in Ireland 1993

  1996cites this paper
• Survival of nosocomial pathogenic bacteria at ambient temperature.

  1996cites this paper
• Ciprofloxacin Resistance Among Nosocomial Pseudomonas aeruginosa and staphylococcus aureus in the United States

  1995cites this paper
• Bacterial resistance to fluoroquinolones: mechanisms and patterns.

  1995cites this paper
• Fluoroquinolone resistance in staphylococci: new challenges.

  1995cites this paper
• [In vitro activity of sparfloxacin against methicillin-resistant staphylococci].

  1995cites this paper
• The fluoroquinolones as treatment for infections caused by gram-positive bacteria.

  1994cites this paper
• The challenge of methicillin-resistant Staphylococcus aureus.

  1994cites this paper
• Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance.

  1994cites this paper
• Bacterial resistance to fluoroquinolones: Lessons to be learned

  1994cites this paper
• Efficacy of ciprofloxacin in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis caused by a cloxacillin-tolerant strain and its non-tolerant variant.

  1994cites this paper
• Methicillin-resistant Staphylococcus aureus in Europe.

  1994cites this paper
• USA resistance patterns among UTI pathogens.

  1994cites this paper
• Bacterial multidrug resistance--emphasis on efflux mechanisms and Pseudomonas aeruginosa.

  1994cites this paper
• Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus

  1993cites this paper
• Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin

  1993cites this paper
• Penicillin-binding proteins and bacterial resistance to beta-lactams

  1993cites this paper
• Mechanisms of antimicrobial resistance and implications for epidemiology.

  1993cites this paper
• Molecular biological characteristics of the antibacterial action of 4-quinolone-3-carboxylic acid derivatives (review)

  1993cites this paper
• Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management.

  1993cites this paper
• Penicillin-Bindi ng Proteins andBacterial Resistance to,3-Lactams

  1993cites this paper
• Correlation of incubating temprature and time on pasteurization of oral bacteria

  1993cites this paper
• Methicillin-Resistant Staphylococcus aureus in Hospitals and Long-Term Care Facilities: Microbiology, Epidemiology, and Preventive Measures

  1992cites this paper
• Strategies in β-lactam Design

  1992cites this paper
• The bactericidal activity of sparfloxacin.

  1992cites this paper
• Review of preclinical studies with ofloxacin.

  1992cites this paper
• A comparison of antimicrobial activity of ofloxacin, L-ofloxacin, and other oral agents for respiratory pathogens.

  1992cites this paper
• In vitro activity of various antimicrobial agents against Staphylococcus aureus isolates including fluoroquinolone- and oxacillin-resistant strains.

  1992cites this paper
• Antibacterial activity of a 1,8-naphthyridine quinolone, PD 131628.

  1992cites this paper
• The rapid emergence of fluoroquinolone-methicillin-resistant Staphylococcus aureus infections in a community hospital. An in vitro look at alternative antimicrobial agents.

  1992cites this paper
• Antibiotic resistance in bacteria.

  1992cites this paper
• Occurrence of quinolone resistance in Staphylococcus aureus from nosocomial infection

  1992cites this paper
• Development of resistance in candida isolates from patients receiving prolonged antifungal therapy

  1991cites this paper
• Emergence of homogeneously methicillin-resistant Staphylococcus aureus

  1991cites this paper
• In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises

  1991cites this paper